Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Pulmonary hypertension Age: Adult: greater than 12 years |
Dose: Oral – 62.5 mg Frequency: twice daily Note: Initial and maintenance dose |
|
Indication: Pulmonary hypertension Age: Adult: greater than 12 years Condition: Initial treatment |
Dose: Oral – 62.5 mg Frequency: twice daily Duration: 4 weeks |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Pulmonary Arterial Hypertension Age: less than 3 years |
Dose: Not applicable – Not applicable Note: Safety and efficacy not established |
|
Indication: Pulmonary Arterial Hypertension Age: 3 to greater than 12 years |
Dose: Maintain dose – 16 mg Frequency: twice daily |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment or dialysis |
Dose: Not specified – Not specified Note: No dosage adjustment needed in renal impairment or dialysis patients. |
Administration
- Take with or without food
- Take at same times
Side Effect
- Hgb decreased, More than 1 g/dL (57%)
- Inhibition of spermatogenesis (25%)
- Headache (16-22%)
- Nasopharyngitis (11%)
- Transaminses increased (12%)
- Respiratory tract infection (22%)
- Increased transaminases (12%)
- Edema
- lower limb (5-8%)
- Flushing (7-9%)
- Hypotension (7%)
- Hepatic abnormalities (4%)
- Palpitations (4%)
- Anemia (3%)
- Dyspepsia (4%)
- Edema, general (4%)
- Fatigue (2%)
- Pruritus (4%)
- Hyperbilirubinemia
- Vasculitis
- Jaundice
- Leukopenia
- Thrombocytopenia
- Leukocytoplastic
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP3A4 inhibitors, CYP2C9 inhibitors
|
Increased bosentan levels
|
|
Rifampicin
|
Initially increases but subsequently decreases concentration
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
WHO Class II Symptoms
|
Risk of hepatotoxicity
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 30°C. Store in a cool and dry place, protected from light. Keep out of children’s reach.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.